OR WAIT null SECS
July 31, 2023
The new facility is set to utilize and extend SCG's capabilities in advanced cell therapy manufacturing and off-the-shelf human-induced Pluripotent Stem Cell (iPSC) technology.
July 28, 2023
Pandemic, PBM, and other policies on hold during the summer recess.
The expansion project is aimed to be completed in December 2024 and the new facility will be fully operational by 2025.
July 27, 2023
Teva Pharmaceuticals and Alvotech will expand their partnership for the development and commercialization of biosimilar candidates.
Roche will pay up to $2.8 billion for the rights to Alnylam’s RNA-based hypertension therapeutic.
Tarsus Pharmaceuticals’ Xdemvy (lotilaner ophthalmic solutions) is designed to treat Demodex blepharitis by directly targeting Demodex mites.
Janssen has received a positive opinion from the EMA for two novel bispecific antibodies, TALVEY (talquetamab) and TECVAYLI (teclistamab), which the company is developing to treat blood cancer.
MilliporeSigma has invested $25 million to expand its cell culture media production facility in Lenexa, Kan.
The partnership is an extension of the collaboration from AbbVie and Scripps Research that was formed in 2019, according to the press release.
July 25, 2023
The damage to the facility, which produces 8% of US injectable drug consumption, should not significantly affect the current supply.